VxP Offers Advanced Vaccine Design and Development Services

We have assembled a leading team to apply new biomanufacturing technologies with existing manufacturing capabilities for biologic products that will provide the our clients with the ability to rapidly respond to emerging disease threats and chemical and biologic events.

Additionally, we are able to leverage our facility and capabilities to provide manufacturing and process development services to the biopharmaceutical industry.  VxP’s primary manufacturing goal is to rapidly produce bulk drug substance according to the highest standards of quality. We offer broad/flexible capabilities including:

  • Development laboratories and pilot plant for performing optimization of upstream, downstream and formulation functions
  • Biologics drug substance cGMP manufacturing space
  • Analytical development

Our manufacturing capabilities include proteins, antibodies, viral, bacterial and recombinant protein vaccines and gene therapy vectors and drug products. We have an integrated team of partners to support product/process development and manufacturing, from the stage of clinical development through the manufacturing of commercial supply. Our highly experienced team provides expertise from preclinical development through final product licensure in all relevant biologics production platforms.